Pricing Log in Create free account

Arvinas, Inc. (ARVN) vs Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY)

Arvinas, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are both Biotechnology companies. Arvinas, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are of similar size ($524.8M and $513.9M). Ceryvyn Therapeutics Ltd. - Unsponsored ADR has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 41.0×. Arvinas, Inc. has the higher net margin (2.94% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Arvinas, Inc. leads on 10 and Ceryvyn Therapeutics Ltd. - Unsponsored ADR on 5.

Valuation

Metric ARVN CYVNY Biotechnology median
P/E 41.04 n/m 12.43
P/S 1.61 2.37 10.53
P/B 0.91 n/m 2.24
Price to free cash flow n/m n/m 22.59
EV/EBITDA 3.19 n/m 0.69
EV/Sales (0.18) 759.28 9.92
Earnings yield 2.44% (2,375.00%) (34.94%)
Free cash flow yield (41.00%) (84,379.36%) (23.17%)

Profitability

Metric ARVN CYVNY Biotechnology median
Gross margin 97.16% 0.00% 68.94%
Operating margin (5.72%) 0.00% 0.00%
Net margin 2.94% (89,724.18%) 0.00%
Free cash flow margin (65.93%) 0.00% 0.00%
Return on equity 1.59% 0.00% (54.09%)
Return on assets 1.17% 0.00% (46.84%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARVN CYVNY Biotechnology median
Revenue growth (TTM) (15.05%) — 6.72%
EPS growth (last fiscal year) 58.84% 61.59% 29.36%
Revenue growth, 5-year CAGR 58.93% (15.81%) 9.96%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARVN CYVNY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.91 0.22 5.00
Net debt to EBITDA 5.62 0.31 1.01

Dividend

Metric ARVN CYVNY Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ARVN CYVNY Biotechnology median
Market cap 513.94m 524.83m 177.44m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack